The Efficacy and Safety of CO
CO2 laser
efficacy
safety
sensation
vaginal laxity
Journal
Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
09
01
2020
revised:
07
05
2020
accepted:
09
05
2020
pubmed:
28
5
2020
medline:
29
10
2021
entrez:
28
5
2020
Statut:
ppublish
Résumé
Vaginal laxity lacks standardized diagnosis and severity criteria. It is considered as a subjective complaint that reflects decreased sexual satisfaction due to vaginal loosening. Treatment modalities have included physiotherapy and plastic surgery. Recently, laser treatments have also gained popularity as a means of relieving gynecological complaints such as pelvic organ prolapse, stress urinary incontinence, and genitourinary syndrome of menopause. The aim of the current study was to evaluate the efficacy of CO For this prospective study, women with reported vaginal laxity and decreased sensation during intercourse were recruited from the Sexual Dysfunction Clinic in our health care campus. Each participant received three outpatient treatments with laser therapy, according to the same protocol. Treatment efficacy was assessed by changes in the Vaginal Health Index (VHI) and Female Sexual Function Index (FSFI). Overall, 84 pre-menopause women, with a mean age of 47.7 years, were included in the study. Mean VHI and FSFI were increased significantly at 3 months post-treatment and decreased again at 6 months post-treatment: 11.8 ± 1.6, 13.5 ± 1.1, and 11.8 ± 1.2, respectively, P = 0.013; and 21.3 ± 1.7, 29.9 ± 1.6, and 22.5 ± 1.8, respectively, P = 0.022. The rate of sexual intercourse doubled during the period of maximal treatment effect (P < 0.0001). CO
Sections du résumé
BACKGROUND AND OBJECTIVES
Vaginal laxity lacks standardized diagnosis and severity criteria. It is considered as a subjective complaint that reflects decreased sexual satisfaction due to vaginal loosening. Treatment modalities have included physiotherapy and plastic surgery. Recently, laser treatments have also gained popularity as a means of relieving gynecological complaints such as pelvic organ prolapse, stress urinary incontinence, and genitourinary syndrome of menopause. The aim of the current study was to evaluate the efficacy of CO
STUDY DESIGN/MATERIALS AND METHODS
For this prospective study, women with reported vaginal laxity and decreased sensation during intercourse were recruited from the Sexual Dysfunction Clinic in our health care campus. Each participant received three outpatient treatments with laser therapy, according to the same protocol. Treatment efficacy was assessed by changes in the Vaginal Health Index (VHI) and Female Sexual Function Index (FSFI).
RESULTS
Overall, 84 pre-menopause women, with a mean age of 47.7 years, were included in the study. Mean VHI and FSFI were increased significantly at 3 months post-treatment and decreased again at 6 months post-treatment: 11.8 ± 1.6, 13.5 ± 1.1, and 11.8 ± 1.2, respectively, P = 0.013; and 21.3 ± 1.7, 29.9 ± 1.6, and 22.5 ± 1.8, respectively, P = 0.022. The rate of sexual intercourse doubled during the period of maximal treatment effect (P < 0.0001).
CONCLUSIONS
CO
Substances chimiques
Carbon Dioxide
142M471B3J
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
199-203Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Qureshi AA, Sharma K, Thornton M, Myckatyn TM, Tenenbaum MM. Vaginal laxity, sexual distress, and sexual dysfunction: A cross-sectional study in a plastic surgery practice. Aesthet Surg J 2018;38:873-880.
Sekiguchi Y, Utsugisawa Y, Azekosi Y, et al. Laxity of the vaginal introitus after childbirth: Nonsurgical outpatient procedure for vaginal tissue restoration and improved sexual satisfaction using low-energy radiofrequency thermal therapy. J Womens Health (Larchmt) 2013;22:775-781.
Moore RD, Miklos JR, Chinthakanan O. Evaluation of sexual function outcomes in women undergoing vaginal rejuvenation/vaginoplasty procedures for symptoms of vaginal laxity/decreased vaginal sensation utilizing validated sexual function questionnaire (PISQ-12). Surg Technol Int 2014;24:253-260.
Dietz HP, Stankiewicz M, Atan IK, Ferreira CW, Socha M. Vaginal laxity: What does this symptom mean? Int Urogynecol J 2018;29:723-728.
Qureshi AA, Tenenbaum MM, Myckatyn TM. Nonsurgical vulvovaginal rejuvenation with radiofrequency and laser devices: A literature review and comprehensive update for aesthetic surgeons. Aesthet Surg J 2018;38:302-311.
Krychman ML. Vaginal laxity issues, answers and implications for female sexual function. J Sex Med 2016;13:1445e1447.
Karcher C, Sadick N. Vaginal rejuvenation using energy-based devices. Int J Women's Dermatol 2016;2:85-88.
Braekken IH, Majida M, Ellström Engh M, Bø K. Can pelvic floor muscle training improve sexual function in women with pelvic organ prolapse? A randomized controlled trial. J Sex Med 2015;12:470-480.
Kolberg Tennfjord M, Hilde G, Staer-Jensen J, Siafarikas F, Ellstróm Engh M, Bø K. Effect of postpartum pelvic floor muscle training on vaginal symptoms and sexual dysfunction-Secondary analysis of a randomised trial. BJOG 2016;3:634-642.
Occhino JA, Trabuco EC, Heisler CA, Klingele CJ, Gebhart JB. Changes in vaginal anatomy and sexual function after vaginal surgery. Int Urogynecol J 2011;22:799-804.
Goodman MP, Placik OJ, Benson RH, III, et al. A large multicenter outcome study of female genital plastic surgery. J Sex Med 2010;7:1565-1577.
Pardo J, Solà VD, Ricci E, Guiloff E, Freundlich O. Colpoperineoplasty in women with a sensation of a wide vagina. Acta Obstet Gynecol Scand 2006;85:1125-1127.
Abedi P, Jamali S, Tadayon M, Parhizkar S, Mogharab F. Effectiveness of selective vaginal tightening on sexual function among reproductive aged women in Iran with vaginal laxity: A quasi-experimental study. J Obstet Gynaecol Res 2014;40:526-531.
Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas 2017;99:10-15.
Arunkalaivanan A, Kaur H, Onuma O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: A critical appraisal of evidence. Int Urogynecol J 2017;28:681-685.
Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol 2015;67:97-102.
Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: A pilot study. Climacteric 2014;17:363-369.
Salvatore S, Leone Roberti Maggiore U, Athanasiou S, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: An ex vivo study. Menopause 2015;22:845-849.
Hutchinson-Colas J, Segal S. Genitourinary syndrome of menopause and the use of laser therapy. Maturitas 2015;82:342-345.
Pieralli A, Fallani MG, Becorpi A, et al. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet 2016;294:841-846.
Arroyo C. Fractional CO2 laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women. Int J Womens Health 2017;9:591-595.
Pagano T, De Rosa P, Vallone R, et al. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer. Menopause 2016;23:1108-1113.
Gambacciani M, Levancini M. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: A pilot study in breast cancer survivors. Menopause 2017;24:316-319.
Salvatore S, Maggiore ULR, Origoni M, et al. Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: A pilot study. J Endometr Pelvic Pain Disord 2014;6:150-156.
Sokol ER, Karram MM. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause 2016;23:1102-1107.
Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 2015;18:219-225.
Alexiades MR. Fractional Co2 laser treatment of the vulva and vagina and the effect of postmenopausal duration on efficacy. Lasers Surg Med 2020. 23247. https://doi.org/10.1002/lsm.23247. PMID: 32329093, [published online ahead of print April 23, 2020].
Takacs P, Sipos AG, Kozma B, Cunningham TD, Larson K, Lampé R, Poka R. The effect of vaginal microablative fractional CO(2) laser treatment on vaginal cytology. Lasers Surg Med 2020. 23211. https://doi.org/10.1002/lsm.23211. PMID: 31919864, [published online ahead of print January 9, 2020].
Sipos AG, Kozma B, Poka R, Larson K, Takacs P. The effect of fractional CO(2) laser treatment on the symptoms of pelvic floor dysfunctions: Pelvic floor distress inventory-20 questionnaire. Lasers Surg Med 2019;51(10):882-886. https://doi.org/10.1002/lsm.23126
Elbiaa AAM, Abdelazim IA, Hussain M, Khalafalla MM. Minimal invasive laser treatment for female stress urinary incontinence. Obstet Gynecol Int J 2015;2(77):80.
Fistonić N, Fistonić I, Guštek ŠF, et al. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women-A pilot study. Lasers Med Sci 2016;31:635-643.
Ogrinc UB, Sencar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med 2015;697:689-697.
Gaviria JE, Lanz JA. Laser Vaginal Tightening (LVT)-evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J Laser Heal Acad Artic 2012;2012:59-66.
Lee MS. Treatment of vaginal relaxation syndrome with an Erbium:YAG Laser using 90° and 360° scanning scopes: A pilot study & short-term results. Laser Ther 2014;23:129-138.
Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: A minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg 2011;28:156-162.
Filippini M, Del Duca E, Negosanti F, et al. Fractional CO2 laser: From skin rejuvenation to vulvo-vaginal reshaping. Photomed Laser Surg 2017;35:171-175.
Lev-Sagie A, Kopitman A, Brzezinski A. Low-level laser therapy for the treatment of provoked vestibulodynia-A randomized, placebo-controlled pilot trial. J Sex Med 2017;14:1403-1411.
Murina F, Karram M, Salvatore S, Felice R. Fractional CO2 laser treatment of the vestibule for patients with vestibulodynia and genitourinary syndrome of menopause: A pilot study. J Sex Med 2016;13:1915-1917.
Drnovšek-Olup B, Beltram M, Pižem J. Repetitive Er:YAG laser irradiation of human skin: A histological evaluation. Lasers Surg Med 2004;35:146-151.
Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci 2014;30:429-436.
Poon VK, Huang L, Burd A. Biostimulation of dermal fibroblast by sublethal Q-switched Nd:YAG 532 nm laser: Collagen remodeling and pigmentation. J Photochem Photobiol B Biol 2005;81:1-8.
Jiang X, Ge H, Zhou C, Chai X, Ren QS. The role of vascular endothelial growth factor in fractional laser resurfacing with the carbon dioxide laser. Lasers Med Sci 2012;27:599-606.
US Food Drug Administration. FDA warns against use of energy-based devices to perform vaginal “rejuvenation” or vaginal cosmetic procedures [Internet]. FDA Safety Communications 2018;34:1509-1511. https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm615013.htm.
Abbas Shobeiri S, Kerkhof MH, Minassian VA, Bazi T. IUGA committee opinion: Laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J 2019;30:371-376.